A review of international biobanks and networks: success factors and key benchmarks
- PMID: 24835880
- PMCID: PMC4046743
- DOI: 10.1089/bio.2010.0003
A review of international biobanks and networks: success factors and key benchmarks
Abstract
Biobanks and biobanking networks are involved in varying degrees in the collection, processing, storage, and dissemination of biological specimens. This review outlines the approaches that 16 of the largest biobanks and biobanking networks in Europe, North America, Australia, and Asia have taken to collecting and distributing human research specimens and managing scientific initiatives while covering operating costs. Many are small operations that exist as either a single or a few freezers in a research laboratory, hospital clinical laboratory, or pathology suite. Larger academic and commercial biobanks operate to support large clinical and epidemiological studies. Operational and business models depend on the medical and research missions of their institutions and home countries. Some national biobanks operate with a centralized physical biobank that accepts samples from multiple locations. Others operate under a "federated" model where each institution maintains its own collections but agrees to list them on a central shared database. Some collections are "project-driven" meaning that specimens are collected and distributed to answer specific research questions. "General" collections are those that exist to establish a reference collection, that is, not to meet particular research goals but to be available to respond to multiple requests for an assortment of research uses. These individual and networked biobanking systems operate under a variety of business models, usually incorporating some form of partial cost recovery, while requiring at least partial public or government funding. Each has a well-defined biospecimen-access policy in place that specifies requirements that must be met-such as ethical clearance and the expertise to perform the proposed experiments-to obtain samples for research. The success of all of these biobanking models depends on a variety of factors including well-defined goals, a solid business plan, and specimen collections that are developed according to strict quality and operational controls.
Similar articles
-
The Future of Biobanking: A Conceptual Look at How Biobanks Can Respond to the Growing Human Biospecimen Needs of Researchers.Adv Exp Med Biol. 2015;864:11-27. doi: 10.1007/978-3-319-20579-3_2. Adv Exp Med Biol. 2015. PMID: 26420610 Review.
-
The landscape of biobanks in Poland-characteristics of Polish biobanking units at the beginning of BBMRI.pl organization.J Transl Med. 2021 Jun 22;19(1):267. doi: 10.1186/s12967-021-02926-y. J Transl Med. 2021. PMID: 34158056 Free PMC article.
-
A strategic plan for the second phase (2013-2015) of the Korea biobank project.Osong Public Health Res Perspect. 2013 Apr;4(2):107-16. doi: 10.1016/j.phrp.2013.03.006. Osong Public Health Res Perspect. 2013. PMID: 24159540 Free PMC article.
-
Advancing Professionalization of Biobank Business Operations: Performance and Utilization.Biopreserv Biobank. 2019 Jun;17(3):213-218. doi: 10.1089/bio.2019.0005. Biopreserv Biobank. 2019. PMID: 31188630 Free PMC article.
-
Biobanking Comes of Age: The Transition to Biospecimen Science.Annu Rev Pharmacol Toxicol. 2016;56:211-28. doi: 10.1146/annurev-pharmtox-010715-103246. Epub 2015 Oct 22. Annu Rev Pharmacol Toxicol. 2016. PMID: 26514206 Review.
Cited by
-
Assessing Researcher Needs for a Virtual Biobank.Biopreserv Biobank. 2017 Jun;15(3):203-210. doi: 10.1089/bio.2016.0009. Epub 2016 Dec 8. Biopreserv Biobank. 2017. PMID: 27929677 Free PMC article.
-
Orchestrating differential data access for translational research: a pilot implementation.BMC Med Inform Decis Mak. 2017 Mar 23;17(1):30. doi: 10.1186/s12911-017-0424-6. BMC Med Inform Decis Mak. 2017. PMID: 28330491 Free PMC article.
-
Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking.J Pers Med. 2023 Sep 16;13(9):1390. doi: 10.3390/jpm13091390. J Pers Med. 2023. PMID: 37763157 Free PMC article. Review.
-
The biobank at the University of Texas Health Science Center at Houston.Biopreserv Biobank. 2015 Jun;13(3):224-5. doi: 10.1089/bio.2015.29004.jes. Biopreserv Biobank. 2015. PMID: 26035014 Free PMC article. No abstract available.
-
A call for global governance of biobanks.Bull World Health Organ. 2015 Feb 1;93(2):113-7. doi: 10.2471/BLT.14.138420. Epub 2014 Nov 24. Bull World Health Organ. 2015. PMID: 25883404 Free PMC article.
References
-
- Australasian Biospecimen Network. ABN—Maximising Valuable Tissue Resources for Researchers. East Melbourne, Victoria, Australia: Australasian Biospecimen Network; 2008. May 28, homepage on the Internet. cited 2009 September 30.
-
- Australian Prostate Cancer BioResource. Welcome to the APCC. Adelaide, SA, Australia: Australian Prostate Cancer BioResource; 2009. Jun, homepage on the Internet. cited 2009 September 30.
-
- Kathleen Cuningham Foundation Consortium for research into Familial Breast cancer. kConFab. East Melbourne, Australia: Kathleen Cuningham Foundation Consortium for research into Familial Breast cancer; 2009. Nov 24, homepage on the Internet. cited 2009 September 30.
-
- Victorian Cancer Bank. Victorian Cancer Bank. Carlton, Victoria, Australia: Victorian Cancer Bank; 2009. Sep 30, homepage on the Internet.
-
- Confederation of Cancer Biobanks. Confederation of Cancer Biobanks. London, England: National Cancer Research Institute; 2009. Apr 2, homepage on the Internet. cited 2009 September 30.
LinkOut - more resources
Full Text Sources
Miscellaneous